ESR1 and breast carcinoma: Studies have shown that with the increase in tumor diameter, pathological grade, and the appearance of positive lymph nodes, ER negative, and PR negative in patients, the abnormal rate of TAP and the area of aggregates show an up-ward trend, suggesting that TAP plays a vital role in the progression of breast cancer (79).